Results 141 to 150 of about 16,475 (253)

Consent for anaesthesia: guidelines from the Association of Anaesthetists

Anaesthesia, EarlyView.
Summary Introduction Guidelines on consent for anaesthesia were first issued by the Association of Anaesthetists in 1999 and last revised in 2017. These new guidelines respond to the changing ethical, legal and clinical landscape in which anaesthetists practice. Since 2017, the Montgomery judgment has changed medical consent practice.
Andrew McLeod, David Bogod, James Brooks, Michael Devlin, Natalie Joseph‐Williams, Rehana Iqbal, Nadine Montgomery‐Allam, Felicity Plaat, Alex Ruck Keene, Cliff Shelton, Vinnie Sodhi, Michael Swart, Emma Wain, Hugo Wellesley, Jenny Westaway   +14 more
wiley   +1 more source

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source

Ranolazine as an adjunct to standard therapy for angina in myocardial bridging: a randomized clinical trial. [PDF]

Sci Rep
Abdi-Ardekani A, Kheirandish N, Rahbarian SY, Imani MH, Arzhangzadeh A, Saem A, Kamali M, Bazroodi H, Neisi S, Mojibpour M, Imani AH, Bazrafshan M, Bazrafshan Drissi H.   +12 more
europepmc   +1 more source

Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang, Melanie Ricke‐Hoch, David Duncker, Johann Bauersachs, Dominik Berliner   +4 more
wiley   +1 more source

Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs

Clinical Endocrinology, EarlyView.
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams, Bonnie Grant, Richard Quinton, Channa N. Jayasena   +3 more
wiley   +1 more source

Incidental Myocardial Bridging Coinciding With Myocardial Ischemia and Takotsubo Cardiomyopathy in an Asymptomatic Patient. [PDF]

Cureus
Khan MZ, Patil A, Suleiman M, Karr J.
europepmc   +1 more source

Reply: Myocardial bridging.

Journal of the American College of Cardiology, 2015
Corban, Michel T., Hung, Olivia Y., Timmins, Lucas H., Samady, Habib   +3 more
openaire   +2 more sources

Targeting m6A Modifications Regulating Ferroptosis Offers Novel Therapy in Diseases

Cell Proliferation, EarlyView.
m6A RNA modification regulates ferroptosis by balancing iron metabolism, lipid peroxidation, and antioxidant defenses. Dysregulated m6A signaling disrupts pro‐ and anti‐ferroptotic factors, leading to excess ROS, Fe3+ accumulation, and lipid peroxidation–driven cell death. Targeting m6A‐mediated ferroptotic regulation represents a promising therapeutic
Lida Du, Joshua S. Fleishman, Shuang Wu, Yuan Zhou, Clara X. Wang, Haitong Wang, Yumin Wang, Hongquan Wang   +7 more
wiley   +1 more source

A Tough Bridge to Cross: Myocardial Bridging Associated With Dehydration-Induced Ischemia in an Endurance Athlete. [PDF]

Cureus
LaGalbo SA, Rao A, Swearingen SP.
europepmc   +1 more source

Association Between Time in Range and Advanced Cardiovascular‐Kidney‐Metabolic Syndrome in Older Adults With Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiovascular, kidney and metabolic diseases are pathophysiologically interrelated and are conceptualised within the cardiovascular‐kidney‐metabolic (CKM) syndrome framework. However, evidence linking continuous glucose monitoring (CGM) to CKM syndrome remains limited.
Hang Su, Jiaying Ni, Jinghao Cai, Wei Zhu, Yufei Wang, Jian Zhou, Jingyi Lu, Xiaojing Ma   +7 more
wiley   +1 more source